Italy· 029020017
FOSICOMBI
A fosinopril und diuretika product containing fosinopril + idroclorotiazide, registered in Italy by A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L., on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Fosinopril und diuretika is registered in 3 of 19 countries.
Countries holding a registration under ATC C09BA09 (fosinopril und diuretika), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 2 of them publish a price we can compare per daily dose
Fosinopril und diuretika · ATC C09BA09
3 / 19 countries
- Czechiaprice
- Italyprice
- Netherlands
The record
At a glance
AIFA (Italy)- Active substance
- Fosinopril + Idroclorotiazide
- Manufacturer
- A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
- Country
- Italy (IT)
- ATC code
- C09BA09
- ATC class
- Fosinopril und Diuretika
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic029020017"20 MG+12,5MG COMPRESSE" 14 COMPRESSEEUR 3.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
67 interactions on record for fosinopril und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosinopril und diuretika · interactions on record
67 records
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Fosinopril und diuretika in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMONACE COMBIBausch Health Ireland Limited, Dublin
- FranceFOSINOPRIL HYDROCHLOROTHIAZIDE ARROW 20 mg/12,5 mg, comprimé sécableARROW GENERIQUES
- United StatesFosinopril Sodium and HydrochlorothiazideCIPLA USA INC.
- SpainFOSINOPRIL /HIDROCLOROTIAZIDA TEVA 20 mg/12,5 mg COMPRIMIDOS EFGTeva Pharma S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Fosicomb, Fosinopril-Natrium/Hct Actavis
- Bulgaria · Монозид
- Czechia · Monace Combi
- Estonia · Fosinopril Hct Actavis
- Spain · Fositens Plus
- France · Fosinopril Hydrochlorothiazide Arrow, Fosinopril/Hydrochlorothiazide Arrow Lab
- Hungary · Duopril, Fosicard Plus
- Lithuania · Fosinopril Hct Actavis
- Latvia · Fosinopril Hct Actavis
- Malta · Fosinopril + Hydrochlorothiazide Aurobindo
- Netherlands · Fosinoprilnatrium/Hydrochloorthiazide Aurobindo
- Portugal · Fosinopril + Hidroclorotiazida Aurobindo, Fosinopril + Hidroclorotiazida Aurovitas
- Slovenia · Monopril Plus
- Slovakia · Monozide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f3b970a-4fff-49f7-acc6-d59266a60da8 GET /v1/drugs/1f3b970a-4fff-49f7-acc6-d59266a60da8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"20 MG+12,5MG COMPRESSE\" 14 COMPRESSE",
"source": "aifa",
"currency": "EUR",
"substance": "Fosinopril + Idroclorotiazide",
"reference_pack": "14 UNITA' (20+12,5) MG - USO ORALE",
"public_price_eur": 3.75,
"ssn_reference_price_eur": 5.72
}See everything about fosinopril und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.